EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Biomarkers of Diabetic Kidney Disease

Jorge Rico-Fontalvo iD, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, José Cabrales iD, Tomás Rodríguez-Yanez iD, María Cardona-Blanco, Juan Montejo-Hernández, Dairo Rodelo Barrios iD, Jhonny Patiño-Patiño, Elber Osorio Rodríguez iD

Biomolecules · 31.03.2023 · 13 (4) · 633

DOI: 10.3390/biom13040633 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 31.03.2023. Verfasst von Jorge Rico-Fontalvo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nephrologist, Colombian Association of Nephrology, Bogota 110221, Colombia. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Type 2, Kidney Failure, Chronic. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a highly prevalent condition worldwide. It represents one of the most common complications arising from diabetes mellitus (DM) and is the leading cause of end-stage kidney disease (ESKD). Its development involves three fundamental components: the hemodynamic, metabolic, and inflammatory axes. Clinically, persistent albuminuria in association with a progressive decline in glomerular filtration rate (GFR) defines this disease. However, as these alterations are not specific to DKD, there is a need to discuss novel biomarkers arising from its pathogenesis which may aid in the diagnosis, follow-up, therapeutic response, and prognosis of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes Mellitus, Type 2Kidney Failure, ChronicHumansGlomerular Filtration RateBiomarkersDisease Progression

Stichwörter der Autor:innen

biomarkersdiabetes mellitusdiabetic kidney diseasepathogenesis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Nephrologist, Colombian Association of Nephrology, Bogota 110221, Colombia.
  • Faculty of Medicine, Universidad Simón Bolívar, Barranquilla 080002, Colombia.
  • Nephrology Fellow, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
  • Internal Medicine, Universidad de Cartagena, Cartagena 130001, Colombia.
  • Graduate Student in Critical Medicine and Intensive Care, Simon Bolivar University, Barranquilla 080002, Colombia.
  • Independent Researcher, Barranquilla 080002, Colombia.

ORCID-Profile: Jorge Rico-Fontalvo, José Cabrales, Tomás Rodríguez-Yanez, Dairo Rodelo Barrios, Elber Osorio Rodríguez

Zitieren

APA

Rico-Fontalvo, J., Aroca-Martínez, G., Daza-Arnedo, R., Cabrales, J., Rodríguez-Yanez, T., Cardona-Blanco, M., Montejo-Hernández, J., Rodelo Barrios, D., Patiño-Patiño, J., & Osorio Rodríguez, E. (2023). Novel Biomarkers of Diabetic Kidney Disease. Biomolecules, 13(4), 633. https://doi.org/10.3390/biom13040633

Vancouver

Rico-Fontalvo J, Aroca-Martínez G, Daza-Arnedo R, Cabrales J, Rodríguez-Yanez T, Cardona-Blanco M, et al. Novel Biomarkers of Diabetic Kidney Disease. Biomolecules. 2023;13(4):633. doi:10.3390/biom13040633

BibTeX
@article{RicoFontalvo2023,
  author = {Rico-Fontalvo, Jorge and Aroca-Martínez, Gustavo and Daza-Arnedo, Rodrigo and Cabrales, José and Rodríguez-Yanez, Tomás and Cardona-Blanco, María and Montejo-Hernández, Juan and Rodelo Barrios, Dairo and Patiño-Patiño, Jhonny and Osorio Rodríguez, Elber},
  title = {Novel Biomarkers of Diabetic Kidney Disease},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {633},
  doi = {10.3390/biom13040633}
}
Kostenlos starten →